Randomised, single-dose study of ARRY 502 in patients with a history of seasonal allergies.
Phase of Trial: Phase I
Latest Information Update: 10 Aug 2011
At a glance
- Drugs ARRY 502 (Primary)
- Indications Allergic asthma; Seasonal allergic rhinitis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 10 Aug 2011 New trial record